Overview
Status
Active
Registry date
2023-11-14
Share capital
30,000.00 PLN
Registered address
ul. Gen. Władysława Sikorskiego 3/2, 53-659 Wrocław, Poland
Electronic delivery address
AE:PL-59225-19893-EETRR-27
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 2 days early.
- 202513/07/2026
- 202414/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Wojciech Fortuna – Management Board Member
Marta Wawrzyniak – Management Board Member
Paweł Tabakow – Management Board Member
Manner of representation
In the case of a multi-member management board, each member of the management board represents the company independently. In the case of a one-person management board, the sole member of the management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wojciech Fortunaage 56 | 150 | $2,025.93 | 25% |
Tomasz Gedeon Olejnikage 54 | 75 | $1,012.97 | 12.5% |
Paweł Tabakowage 51 | 225 | $3,038.90 | 37.5% |
Marta Wawrzyniakage 38 | 75 | $1,012.97 | 12.5% |
Others | 75 | $1,012.97 | 12.5% |
Beneficial owners
No beneficial owners recorded for the company Ptwf.
Bank accounts
Registered as a VAT taxpayer on 2023-12-01.
24 1050 1575 1000 0090 3300 1414
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of Ptwf focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on November 14, 2023.
The headquarters is located at: ul. Gen. Władysława Sikorskiego 3, 53-659 Wrocław.
The share capital of the company is PLN 30,000 (approx. $8,104).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07